Rapidly Dissolving Microneedle Patch of Amphotericin-B for Intracorneal Fungal Infections. Article Swipe
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-486620/v1
Chronic fungal infection of the cornea could lead to blindness if not treated properly. Topical AMP-B is considered the first treatment of choice for ocular fungal infection. However, factors related to its poor solubility and penetration through intact cornea leads to poor bioavailability. Microneedles (MNs) are emerging as a minimally-invasive method to enhance ocular drug delivery. Therefore, this study aims to investigate the potential use of biodegradable poly(vinylpyrrolidone) (PVP) and hyaluronic acid (HA) based rapidly dissolving MNs for delivery of AMP-B to treat fungal infection. The data obtained illustrates PVP/HA MN arrays' reproducibility, good mechanical strength, and faster dissolution with 100% drug recovery. Multiphoton microscopic results revealed that MNs as microdevice successfully penetrate the corneal tissue and enhance AMP-B permeation through corneal layers. Furthermore, PVP/HA MNs arrays showed high solubility. Both PVP and HA successfully decreased AMP-B cytotoxicity when compared to free drug. More interestingly, the biocompatible MN formulations preserved the antifungal activity of AMP-B, as demonstrated by significant inhibition of fungal growth. Therefore, this study shows the feasibility of ocular delivery of the poorly soluble AMP-B using a fast-dissolving MN patch.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.21203/rs.3.rs-486620/v1
- https://www.researchsquare.com/article/rs-486620/latest.pdf
- OA Status
- gold
- Cited By
- 12
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4230475414
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4230475414Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21203/rs.3.rs-486620/v1Digital Object Identifier
- Title
-
Rapidly Dissolving Microneedle Patch of Amphotericin-B for Intracorneal Fungal Infections.Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-05-13Full publication date if available
- Authors
-
Alyaa A. Albadr, Ismaiel A. Tekko, Lalitkumar K. Vora, Ahlam Ali, Garry Laverty, Ryan F. Donnelly, Thakur Raghu Raj SinghList of authors in order
- Landing page
-
https://doi.org/10.21203/rs.3.rs-486620/v1Publisher landing page
- PDF URL
-
https://www.researchsquare.com/article/rs-486620/latest.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.researchsquare.com/article/rs-486620/latest.pdfDirect OA link when available
- Concepts
-
Amphotericin B, Dissolution, Medicine, Microbiology, Chemistry, Dermatology, Antifungal, Biology, Organic chemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
12Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 6, 2023: 2, 2022: 1, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4230475414 |
|---|---|
| doi | https://doi.org/10.21203/rs.3.rs-486620/v1 |
| ids.doi | https://doi.org/10.21203/rs.3.rs-486620/v1 |
| ids.openalex | https://openalex.org/W4230475414 |
| fwci | 1.07709192 |
| type | preprint |
| title | Rapidly Dissolving Microneedle Patch of Amphotericin-B for Intracorneal Fungal Infections. |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10704 |
| topics[0].field.id | https://openalex.org/fields/30 |
| topics[0].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[0].score | 0.9983999729156494 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3003 |
| topics[0].subfield.display_name | Pharmaceutical Science |
| topics[0].display_name | Advancements in Transdermal Drug Delivery |
| topics[1].id | https://openalex.org/T10150 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9950000047683716 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Antifungal resistance and susceptibility |
| topics[2].id | https://openalex.org/T11253 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9947999715805054 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Nail Diseases and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779629538 |
| concepts[0].level | 3 |
| concepts[0].score | 0.848522424697876 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q412223 |
| concepts[0].display_name | Amphotericin B |
| concepts[1].id | https://openalex.org/C88380143 |
| concepts[1].level | 2 |
| concepts[1].score | 0.47319361567497253 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q416674 |
| concepts[1].display_name | Dissolution |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.44000160694122314 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C89423630 |
| concepts[3].level | 1 |
| concepts[3].score | 0.41627514362335205 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[3].display_name | Microbiology |
| concepts[4].id | https://openalex.org/C185592680 |
| concepts[4].level | 0 |
| concepts[4].score | 0.3483361601829529 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[4].display_name | Chemistry |
| concepts[5].id | https://openalex.org/C16005928 |
| concepts[5].level | 1 |
| concepts[5].score | 0.2332325577735901 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[5].display_name | Dermatology |
| concepts[6].id | https://openalex.org/C2779548794 |
| concepts[6].level | 2 |
| concepts[6].score | 0.21929949522018433 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q578726 |
| concepts[6].display_name | Antifungal |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.10525515675544739 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C178790620 |
| concepts[8].level | 1 |
| concepts[8].score | 0.06443563103675842 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[8].display_name | Organic chemistry |
| keywords[0].id | https://openalex.org/keywords/amphotericin-b |
| keywords[0].score | 0.848522424697876 |
| keywords[0].display_name | Amphotericin B |
| keywords[1].id | https://openalex.org/keywords/dissolution |
| keywords[1].score | 0.47319361567497253 |
| keywords[1].display_name | Dissolution |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.44000160694122314 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/microbiology |
| keywords[3].score | 0.41627514362335205 |
| keywords[3].display_name | Microbiology |
| keywords[4].id | https://openalex.org/keywords/chemistry |
| keywords[4].score | 0.3483361601829529 |
| keywords[4].display_name | Chemistry |
| keywords[5].id | https://openalex.org/keywords/dermatology |
| keywords[5].score | 0.2332325577735901 |
| keywords[5].display_name | Dermatology |
| keywords[6].id | https://openalex.org/keywords/antifungal |
| keywords[6].score | 0.21929949522018433 |
| keywords[6].display_name | Antifungal |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.10525515675544739 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/organic-chemistry |
| keywords[8].score | 0.06443563103675842 |
| keywords[8].display_name | Organic chemistry |
| language | en |
| locations[0].id | doi:10.21203/rs.3.rs-486620/v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.researchsquare.com/article/rs-486620/latest.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.21203/rs.3.rs-486620/v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5076777877 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9375-1388 |
| authorships[0].author.display_name | Alyaa A. Albadr |
| authorships[0].countries | IQ |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I126633494 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Basrah |
| authorships[0].institutions[0].id | https://openalex.org/I126633494 |
| authorships[0].institutions[0].ror | https://ror.org/00840ea57 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I126633494 |
| authorships[0].institutions[0].country_code | IQ |
| authorships[0].institutions[0].display_name | University of Basrah |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alyaa A. Albadr |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Basrah |
| authorships[1].author.id | https://openalex.org/A5002441928 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8317-2216 |
| authorships[1].author.display_name | Ismaiel A. Tekko |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[1].affiliations[0].raw_affiliation_string | Queen's University Belfast |
| authorships[1].institutions[0].id | https://openalex.org/I126231945 |
| authorships[1].institutions[0].ror | https://ror.org/00hswnk62 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | Queen's University Belfast |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ismaiel A. Tekko |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Queen's University Belfast |
| authorships[2].author.id | https://openalex.org/A5058455782 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8106-9066 |
| authorships[2].author.display_name | Lalitkumar K. Vora |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[2].affiliations[0].raw_affiliation_string | Queen's University Belfast |
| authorships[2].institutions[0].id | https://openalex.org/I126231945 |
| authorships[2].institutions[0].ror | https://ror.org/00hswnk62 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Queen's University Belfast |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Lalitkumar K. Vora |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Queen's University Belfast |
| authorships[3].author.id | https://openalex.org/A5027801789 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Ahlam Ali |
| authorships[3].countries | GB |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[3].affiliations[0].raw_affiliation_string | Queen's University Belfast |
| authorships[3].institutions[0].id | https://openalex.org/I126231945 |
| authorships[3].institutions[0].ror | https://ror.org/00hswnk62 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[3].institutions[0].country_code | GB |
| authorships[3].institutions[0].display_name | Queen's University Belfast |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ahlam A. Ali |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Queen's University Belfast |
| authorships[4].author.id | https://openalex.org/A5005541110 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1435-2942 |
| authorships[4].author.display_name | Garry Laverty |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[4].affiliations[0].raw_affiliation_string | Queen's University Belfast |
| authorships[4].institutions[0].id | https://openalex.org/I126231945 |
| authorships[4].institutions[0].ror | https://ror.org/00hswnk62 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | Queen's University Belfast |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Garry Laverty |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Queen's University Belfast |
| authorships[5].author.id | https://openalex.org/A5035668087 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0766-4147 |
| authorships[5].author.display_name | Ryan F. Donnelly |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I126231945 |
| authorships[5].affiliations[0].raw_affiliation_string | Queen's University Belfast |
| authorships[5].institutions[0].id | https://openalex.org/I126231945 |
| authorships[5].institutions[0].ror | https://ror.org/00hswnk62 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I126231945 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | Queen's University Belfast |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ryan F. Donnelly |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Queen's University Belfast |
| authorships[6].author.id | https://openalex.org/A5018062304 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-7582-2082 |
| authorships[6].author.display_name | Thakur Raghu Raj Singh |
| authorships[6].countries | BD, GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I126231945, https://openalex.org/I4210096394 |
| authorships[6].affiliations[0].raw_affiliation_string | Queens University Belfast |
| authorships[6].institutions[0].id | https://openalex.org/I4210096394 |
| authorships[6].institutions[0].ror | https://ror.org/00strmv13 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210096394 |
| authorships[6].institutions[0].country_code | BD |
| authorships[6].institutions[0].display_name | Queens University |
| authorships[6].institutions[1].id | https://openalex.org/I126231945 |
| authorships[6].institutions[1].ror | https://ror.org/00hswnk62 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I126231945 |
| authorships[6].institutions[1].country_code | GB |
| authorships[6].institutions[1].display_name | Queen's University Belfast |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Raghu Raj Thakur |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Queens University Belfast |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.researchsquare.com/article/rs-486620/latest.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Rapidly Dissolving Microneedle Patch of Amphotericin-B for Intracorneal Fungal Infections. |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10704 |
| primary_topic.field.id | https://openalex.org/fields/30 |
| primary_topic.field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| primary_topic.score | 0.9983999729156494 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3003 |
| primary_topic.subfield.display_name | Pharmaceutical Science |
| primary_topic.display_name | Advancements in Transdermal Drug Delivery |
| related_works | https://openalex.org/W4387497383, https://openalex.org/W2948807893, https://openalex.org/W2899084033, https://openalex.org/W2778153218, https://openalex.org/W2748952813, https://openalex.org/W1531601525, https://openalex.org/W4391375266, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762 |
| cited_by_count | 12 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 1 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21203/rs.3.rs-486620/v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.researchsquare.com/article/rs-486620/latest.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-486620/v1 |
| primary_location.id | doi:10.21203/rs.3.rs-486620/v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.researchsquare.com/article/rs-486620/latest.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-486620/v1 |
| publication_date | 2021-05-13 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W6673046234, https://openalex.org/W2767031614, https://openalex.org/W6655196264, https://openalex.org/W2134122507, https://openalex.org/W2100012897, https://openalex.org/W2792337208, https://openalex.org/W1983462777, https://openalex.org/W2114508410, https://openalex.org/W2553192892, https://openalex.org/W2168701063, https://openalex.org/W7075587235, https://openalex.org/W1967051901, https://openalex.org/W6602503091, https://openalex.org/W3116236574, https://openalex.org/W3043062243, https://openalex.org/W2809889451, https://openalex.org/W3112662157, https://openalex.org/W2762614634, https://openalex.org/W2531808727, https://openalex.org/W2499467511, https://openalex.org/W3082455013, https://openalex.org/W3037569530, https://openalex.org/W2146638813, https://openalex.org/W2988894917, https://openalex.org/W2065845122, https://openalex.org/W1974989774, https://openalex.org/W2737936001, https://openalex.org/W3043277174, https://openalex.org/W2113522006, https://openalex.org/W2139359833, https://openalex.org/W3134060153, https://openalex.org/W3030748152, https://openalex.org/W2042973099, https://openalex.org/W1999657637, https://openalex.org/W1966243426, https://openalex.org/W2137828531, https://openalex.org/W2583665135, https://openalex.org/W2132349584, https://openalex.org/W2064185190, https://openalex.org/W2133039915, https://openalex.org/W2183080608, https://openalex.org/W2061894085, https://openalex.org/W2021627022, https://openalex.org/W2121511326, https://openalex.org/W820538051, https://openalex.org/W2783984025, https://openalex.org/W2018498175, https://openalex.org/W2757444754, https://openalex.org/W2090506023, https://openalex.org/W2025122136 |
| referenced_works_count | 50 |
| abstract_inverted_index.a | 49, 179 |
| abstract_inverted_index.HA | 134 |
| abstract_inverted_index.MN | 91, 148, 181 |
| abstract_inverted_index.as | 48, 110, 156 |
| abstract_inverted_index.by | 158 |
| abstract_inverted_index.if | 11 |
| abstract_inverted_index.is | 17 |
| abstract_inverted_index.of | 4, 22, 66, 80, 154, 161, 170, 173 |
| abstract_inverted_index.to | 9, 31, 41, 52, 61, 82, 141 |
| abstract_inverted_index.MNs | 77, 109, 126 |
| abstract_inverted_index.PVP | 132 |
| abstract_inverted_index.The | 86 |
| abstract_inverted_index.and | 35, 70, 97, 117, 133 |
| abstract_inverted_index.are | 46 |
| abstract_inverted_index.for | 24, 78 |
| abstract_inverted_index.its | 32 |
| abstract_inverted_index.not | 12 |
| abstract_inverted_index.the | 5, 19, 63, 114, 146, 151, 168, 174 |
| abstract_inverted_index.use | 65 |
| abstract_inverted_index.(HA) | 73 |
| abstract_inverted_index.100% | 101 |
| abstract_inverted_index.Both | 131 |
| abstract_inverted_index.More | 144 |
| abstract_inverted_index.acid | 72 |
| abstract_inverted_index.aims | 60 |
| abstract_inverted_index.data | 87 |
| abstract_inverted_index.drug | 55, 102 |
| abstract_inverted_index.free | 142 |
| abstract_inverted_index.good | 94 |
| abstract_inverted_index.high | 129 |
| abstract_inverted_index.lead | 8 |
| abstract_inverted_index.poor | 33, 42 |
| abstract_inverted_index.that | 108 |
| abstract_inverted_index.this | 58, 165 |
| abstract_inverted_index.when | 139 |
| abstract_inverted_index.with | 100 |
| abstract_inverted_index.(MNs) | 45 |
| abstract_inverted_index.(PVP) | 69 |
| abstract_inverted_index.AMP-B | 16, 81, 119, 137, 177 |
| abstract_inverted_index.based | 74 |
| abstract_inverted_index.could | 7 |
| abstract_inverted_index.drug. | 143 |
| abstract_inverted_index.first | 20 |
| abstract_inverted_index.leads | 40 |
| abstract_inverted_index.shows | 167 |
| abstract_inverted_index.study | 59, 166 |
| abstract_inverted_index.treat | 83 |
| abstract_inverted_index.using | 178 |
| abstract_inverted_index.AMP-B, | 155 |
| abstract_inverted_index.PVP/HA | 90, 125 |
| abstract_inverted_index.arrays | 127 |
| abstract_inverted_index.choice | 23 |
| abstract_inverted_index.cornea | 6, 39 |
| abstract_inverted_index.faster | 98 |
| abstract_inverted_index.fungal | 2, 26, 84, 162 |
| abstract_inverted_index.intact | 38 |
| abstract_inverted_index.method | 51 |
| abstract_inverted_index.ocular | 25, 54, 171 |
| abstract_inverted_index.patch. | 182 |
| abstract_inverted_index.poorly | 175 |
| abstract_inverted_index.showed | 128 |
| abstract_inverted_index.tissue | 116 |
| abstract_inverted_index.Chronic | 1 |
| abstract_inverted_index.Topical | 15 |
| abstract_inverted_index.arrays' | 92 |
| abstract_inverted_index.corneal | 115, 122 |
| abstract_inverted_index.enhance | 53, 118 |
| abstract_inverted_index.factors | 29 |
| abstract_inverted_index.growth. | 163 |
| abstract_inverted_index.layers. | 123 |
| abstract_inverted_index.rapidly | 75 |
| abstract_inverted_index.related | 30 |
| abstract_inverted_index.results | 106 |
| abstract_inverted_index.soluble | 176 |
| abstract_inverted_index.through | 37, 121 |
| abstract_inverted_index.treated | 13 |
| abstract_inverted_index.However, | 28 |
| abstract_inverted_index.activity | 153 |
| abstract_inverted_index.compared | 140 |
| abstract_inverted_index.delivery | 79, 172 |
| abstract_inverted_index.emerging | 47 |
| abstract_inverted_index.obtained | 88 |
| abstract_inverted_index.revealed | 107 |
| abstract_inverted_index.blindness | 10 |
| abstract_inverted_index.decreased | 136 |
| abstract_inverted_index.delivery. | 56 |
| abstract_inverted_index.infection | 3 |
| abstract_inverted_index.penetrate | 113 |
| abstract_inverted_index.potential | 64 |
| abstract_inverted_index.preserved | 150 |
| abstract_inverted_index.properly. | 14 |
| abstract_inverted_index.recovery. | 103 |
| abstract_inverted_index.strength, | 96 |
| abstract_inverted_index.treatment | 21 |
| abstract_inverted_index.Therefore, | 57, 164 |
| abstract_inverted_index.antifungal | 152 |
| abstract_inverted_index.considered | 18 |
| abstract_inverted_index.dissolving | 76 |
| abstract_inverted_index.hyaluronic | 71 |
| abstract_inverted_index.infection. | 27, 85 |
| abstract_inverted_index.inhibition | 160 |
| abstract_inverted_index.mechanical | 95 |
| abstract_inverted_index.permeation | 120 |
| abstract_inverted_index.solubility | 34 |
| abstract_inverted_index.Multiphoton | 104 |
| abstract_inverted_index.dissolution | 99 |
| abstract_inverted_index.feasibility | 169 |
| abstract_inverted_index.illustrates | 89 |
| abstract_inverted_index.investigate | 62 |
| abstract_inverted_index.microdevice | 111 |
| abstract_inverted_index.microscopic | 105 |
| abstract_inverted_index.penetration | 36 |
| abstract_inverted_index.significant | 159 |
| abstract_inverted_index.solubility. | 130 |
| abstract_inverted_index.Furthermore, | 124 |
| abstract_inverted_index.Microneedles | 44 |
| abstract_inverted_index.cytotoxicity | 138 |
| abstract_inverted_index.demonstrated | 157 |
| abstract_inverted_index.formulations | 149 |
| abstract_inverted_index.successfully | 112, 135 |
| abstract_inverted_index.biocompatible | 147 |
| abstract_inverted_index.biodegradable | 67 |
| abstract_inverted_index.interestingly, | 145 |
| abstract_inverted_index.fast-dissolving | 180 |
| abstract_inverted_index.bioavailability. | 43 |
| abstract_inverted_index.reproducibility, | 93 |
| abstract_inverted_index.minimally-invasive | 50 |
| abstract_inverted_index.poly(vinylpyrrolidone) | 68 |
| abstract_inverted_index.<title>Abstract</title> | 0 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5018062304 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I126231945, https://openalex.org/I4210096394 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6000000238418579 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.69817927 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |